OREX

Orexigen Therapeutics, Inc. News Headlines

$5.98
*  
0.01
0.17%
Get OREX Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Mid-Morning Market Update: Markets Drop; H&R Block Posts Higher Profit
6/11/2014 9:13:50 AM - Benzinga


Futures Drift Lower As Lower Global Growth Forecasts, Cautious Investors Weigh on Equities
6/11/2014 8:17:31 AM - MT Newswires


Pre-Market Most Active for Jun 11, 2014 : ING, MTU, BAC, ACHN, OREX, MU, LYG, FB, OSUR, AAPL, NVO, TWTR
6/11/2014 7:39:53 AM - NASDAQ.com News


Orexigen Investors Hope For FDA Approval
6/10/2014 1:22:00 PM - Seeking Alpha


Orexigen Could Be A Double-Edged Sword For Arena
6/9/2014 5:22:00 PM - Seeking Alpha


Orexigen's Upcoming Pipeline Catalyst - Analyst Blog
6/9/2014 3:45:00 PM - Zacks.com


Arena Pharmaceuticals: Strong Sell On Multiple Red Flags
6/6/2014 1:15:00 PM - Seeking Alpha


Orexigen To Rise On Very Likely FDA Nod June 11th
6/6/2014 11:58:00 AM - Seeking Alpha


The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming
6/2/2014 8:30:00 AM - Seeking Alpha


Belviq Sales Climb - Are Ads Effective?
5/30/2014 4:46:00 PM - Seeking Alpha


Orexigen (OREX) in Focus: Stock Moves 6.1% Higher - Tale of the Tape
5/29/2014 8:46:00 AM - Zacks.com


Aspen Investment Said To Be Offering $640 Million For Vivus
5/28/2014 4:56:00 PM - Seeking Alpha


Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why
5/28/2014 8:30:00 AM - Seeking Alpha


Arena To Present At Jefferies Conference - Is It A Catalyst?
5/27/2014 5:18:00 PM - Seeking Alpha


Orexigen Will Run: Here's Why
5/27/2014 3:47:00 PM - Seeking Alpha


2nd Half Of 2014 Biotechnology Catalysts: Part 1
5/27/2014 9:34:00 AM - Seeking Alpha


Arena's Belviq Sales Flat-To-Slightly Down
5/23/2014 2:37:00 PM - Seeking Alpha


FDA Panel to Review Novo Nordisk's Victoza 3mg - Analyst Blog
5/21/2014 4:35:00 PM - Zacks.com


Trials Are Expected In Japan And China, But Arena's Belviq International Sales Will Have To Wait
5/14/2014 1:45:00 AM - Seeking Alpha


Wider-than-Expected Loss at Orexigen in Q1 - Analyst Blog
5/12/2014 8:50:00 AM - Zacks.com


Vivus Discloses Competitive Threat
5/10/2014 10:51:00 AM - Seeking Alpha


After Hours Most Active for May 8, 2014 : LLY, BAC, QQQ, MSFT, ATML, RVT, MCP, SIRI, MRK, NEE^O, FB, OREX
5/8/2014 3:44:59 PM - NASDAQ.com News


Vivus Impresses Street - Can It Last?
5/6/2014 12:38:00 PM - Seeking Alpha


Will Arena Seize An Opportunity?
5/6/2014 12:35:00 PM - Seeking Alpha


Vivus Earnings On Tap
5/5/2014 1:13:00 PM - Seeking Alpha